共 38 条
- [21] Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinomaCell Communication and Signaling, 21Sang Hyun SeoKyung Joo ChoHye Jung ParkHye Won LeeBeom Kyung KimJun Yong ParkDo Young KimSang Hoon AhnJae Hee CheonJong In YookMan-Deuk KimDong Jin JooSeung Up Kim
- [22] Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinomaCELL COMMUNICATION AND SIGNALING, 2023, 21 (01)Seo, Sang HyunCho, Kyung JooPark, Hye JungLee, Hye WonKim, Beom KyungPark, Jun YongKim, Do YoungAhn, Sang HoonCheon, Jae HeeYook, Jong InKim, Man-DeukJoo, Dong JinKim, Seung Up
- [23] EFFECT OF CO-ADMINISTRATION OF URACIL OR CYTOSINE ON THE ANTI-TUMOR ACTIVITY OF CLINICAL DOSES OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL AND LEVEL OF 5-FLUOROURACIL IN RODENTSGANN, 1979, 70 (02): : 209 - 214FUJII, SKITANO, SIKENAKA, KSHIRASAKA, T
- [24] Ganoderma lucidum put forth anti-tumor activity against PC-3 prostate cancer cells via inhibition of Jak-1/STAT-3 activitySAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2020, 27 (10) : 2632 - 2637Wang, XiaomingWang, BoZhou, LiquanWang, XiangVeeraraghavan, Vishnu PriyaMohan, Surapaneni KrishnaXin, Feng
- [25] VS-5584 a dual mTORC1/2 and PI3K inhibitor has anti-tumor activity in multiple in vivo xenograft tumor models and enhanced efficacy in combination with cisplatin or docetaxelCANCER RESEARCH, 2014, 74 (19)Trombino, Anthony F.Kolev, Vihren N.Wright, Quentin G.Xu, QunliPadval, Mahesh V.
- [26] Preclinical development of the CDK4 selective inhibitor PF-07220060: Increased CDK4 versus CDK6 inhibition leads to improved anti-tumor efficacy at therapeutic concentrationsCANCER RESEARCH, 2024, 84 (06)Anders, LarsPascual, BernadetteBoras, BrittonCianfrogna, JulieGarza, ScottLi, NaYuan, Jing TangMoen, MarkHuser, NanniGallego, GaryJalaie, MehranNinkovic, SachaCho-Schultz, SujinShen, HongKath, JohnDress, KlausDiehl, WadeNair, SajivJones, RhysLafontaine, JenniferMurtaza, AnwarSacaan, AidaChintharlapalli, SudhakarVanArsdale, Todd
- [27] Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signalingJOURNAL OF CONTROLLED RELEASE, 2021, 332 : 563 - 580Sivak, LadislavSubr, VladimirKovarova, JirinaDvorakova, BarboraSirova, MiladaSihova, BlankaRandarova, EvaKraus, MichalTomala, JakubStudenovsky, MartinVondrackova, MichaelaSedlacek, RadislavMakovicky, PetrFucikova, JitkaVosahlikova, SarkaSpisek, RadekKostka, LiborEtrych, TomasKovar, Marek
- [28] The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cellsJournal of Experimental & Clinical Cancer Research, 37Daniele CretellaAndrea RavelliClaudia FumarolaSilvia La MonicaGraziana DigiacomoAndrea CavazzoniRoberta AlfieriAlessandra BiondiDaniele GeneraliMara BonelliPier Giorgio Petronini
- [29] The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cellsJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37Cretella, DanieleRavelli, AndreaFumarola, ClaudiaLa Monica, SilviaDigiacomo, GrazianaCavazzoni, AndreaAlfieri, RobertaBiondi, AlessandraGenerali, DanieleBonelli, MaraPetronini, Pier Giorgio
- [30] The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activityMOLECULAR CANCER, 2010, 9Bill, Matthew A.Fuchs, James R.Li, ChenglongYui, JenniferBakan, CourtneyBenson, Don M., Jr.Schwartz, Eric B.Abdelhamid, DaliaLin, JiayuhHoyt, Dale G.Fossey, Stacey L.Young, Gregory S.Carson, William E., IIILi, Pui-KaiLesinski, Gregory B.